Reddit Posts
Mentions
IMRX is one of the best plays to make money over the next 6 months . RZLV has some major potential if the audited financials are what they claim . DGXX has contract news coming soon. This will be easy money as long as bitcoin doesn’t drop too much before then LFMD is near 52 week low, even though they paid off all debt and are in the best financial position they have ever been in. This is a great one to DCA until march when earnings come out .
SLS, IMRX, MAIA and CHRS are up 60-200% for me. I recently had GPCR and NRXS double/sold too. I got lucky with them I'll admit but biotech is still a favourite. I wouldn't recommend yolo'ing 10k into one stock though.
I’ve been making some nice money on **$BLNE** thanks to you — much appreciated. At this point, I’m thinking I might as well just follow you into battle. So here’s the plan: * **$LFMD** instead of **$HIMS**, * **$DGXX** instead of **$IREN**, * **$IMRX** instead of **$IBRX**. No hedging, no overthinking — just vibes and conviction. It’s officially all or nothing. Hopefully by year-end, I’ll be sipping a mojito in the Maldives. Wishing you the best of luck — and let’s see how it plays out.
DGXX , LFMD , IMRX , RZLV . These are getting my money at current prices
IMRX - immuneering— no debt , insiders buys like crazy lately , already funded through 2029 so no dilution. Their phase 2 readout wasn’t even bad at all, and the market over reacted like crazy. Their overall survival rate was 64%, and the market was hoping for 75%. But the 64% is still nearly double the standard of care . Also the 64% was after 13 1/2 months, not 12 months . So it might have been a little higher . In my opinion, this is one of the best upside potentials on the market. I’ve been loading up since the low $4 range, and I’ll keep buying until $6.50, then letting it ride until halfway through phase 3 trials when I re evaluate. Phase 3 starts in June, and they have tumor shrinkage updates coming soon, along with a couple another potential catalysts. They have like $240m in cash. So it’s not a risk of any dilution. CEO said they are funded through 2029. The upside potential is huge on this one . They partnered with LLY and some other big names . I started buying at $1.50, and rode it up to like $9. Then bought again at $5.50 and rode it to $8. Now I’ve been loading again .
IMRX - immuneering— no debt , insiders buys like crazy lately , already funded through 2029 so no dilution. Their phase 2 readout wasn’t even bad at all, and the market over reacted like crazy. Their overall survival rate was 64%, and the market was hoping for 75%. But the 64% is still nearly double the standard of care . Also the 64% was after 13 1/2 months, not 12 months . So it might have been a little higher . In my opinion, this is one of the best upside potentials on the market. I’ve been loading up since the low $4 range, and I’ll keep buying until $6.50, then letting it ride until halfway through phase 3 trials when I re evaluate. Phase 3 starts in June, and they have tumor shrinkage updates coming soon, along with a couple another potential catalysts. They have like $240m in cash. So it’s not a risk of any dilution. CEO said they are funded through 2029. The upside potential is huge on this one . They partnered with LLY and some other big names . I started buying at $1.50, and rode it up to like $9. Then bought again at $5.50 and rode it to $8. Now I’ve been loading again .
I’ve been adding a lot the last few weeks. Planning to hold until at least halfway through phase 3 trials on this one. IMRX has been one of the best stocks to make money the past couple weeks. The massive market over reaction was great !
I bought the dip at 4.8, market expecting >70% but it came at 64% hence the sell off. IMRX has better positioning versus SLS.
IMRX — no debt , insiders buys like crazy lately , already funded through 2029 so no dilution. Their phase 2 readout wasn’t even bad at all, and the market over reacted like crazy. Their overall survival rate was 64%, and the market was hoping for 75%. But the 64% is still nearly double the standard of care . Also the 64% was after 13 1/2 months, not 12 months . So it might have been a little higher . In my opinion, this is one of the best upside potentials on the market. I’ve been loading up since the low $4 range, and I’ll keep buying until $6.50, then letting it ride until halfway through phase 3 trials when I re evaluate. Phase 3 starts in June, and they have tumor shrinkage updates coming soon, along with a couple another potential catalysts. They have like $240m in cash. So it’s not a risk of any dilution. CEO said they are funded through 2029. The upside potential is huge on this one . They partnered with LLY and some other big names . I started buying at $1.50, and rode it up to like $9. Then bought again at $5.50 and rode it to $8. Now I’ve been loading again .
IMRX — no debt , insiders buys like crazy lately , already funded through 2029 so no dilution. Their phase 2 readout wasn’t even bad at all, and the market over reacted like crazy. Their overall survival rate was 64%, and the market was hoping for 75%. But the 64% is still nearly double the standard of care . Also the 64% was after 13 1/2 months, not 12 months . So it might have been a little higher . In my opinion, this is one of the best upside potentials on the market. I’ve been loading up since the low $4 range, and I’ll keep buying until $6.50, then letting it ride until halfway through phase 3 trials when I re evaluate. Phase 3 starts in June, and they have tumor shrinkage updates coming soon, along with a couple another potential catalysts. They have like $240m in cash. So it’s not a risk of any dilution. CEO said they are funded through 2029. The upside potential is huge on this one . They partnered with LLY and some other big names . I started buying at $1.50, and rode it up to like $9. Then bought again at $5.50 and rode it to $8. Now I’ve been loading again .
No, I mean IMRX - immuneering
Do you mean IBRX instead of IMRX?
IMRX — no debt , insiders buys like crazy lately , already funded through 2029 so no dilution. Their phase 2 readout wasn’t even bad at all, and the market over reacted like crazy. Their overall survival rate was 64%, and the market was hoping for 75%. But the 64% is still nearly double the standard of care . Also the 64% was after 13 1/2 months, not 12 months . So it might have been a little higher . In my opinion, this is one of the best upside potentials on the market. I’ve been loading up since the low $4 range, and I’ll keep buying until $6.50, then letting it ride until halfway through phase 3 trials when I re evaluate. Phase 3 starts in June, and they have tumor shrinkage updates coming soon, along with a couple another potential catalysts. They have like $240m in cash. So it’s not a risk of any dilution. CEO said they are funded through 2029. The upside potential is huge on this one . They partnered with LLY and some other big names . I started buying at $1.50, and rode it up to like $9. Then bought again at $5.50 and rode it to $8. Now I’ve been loading again .
IMRX - been buying like crazy after a massive over reaction a few weeks . The insiders have been loading up the past couple weeks. The company has no debt . They are funded through 2029, so there’s no dilution worry. Their news wasn’t bad in any way a few weeks ago. The overall survival rate was 64%, when the standard of care is like 34%. The readout was also after 13 1/2 months instead of 12 months . Phase 3 trials start in June. There’s some tumor shrinkage news coming out before then. I bought a bunch when it was $1.50, and rode it to $9. There was a big after hours short squeeze back in September when they did a readout after hours. It went from like $9 to $17 before announcing a share offering . The upside potential on this is excellent. I plan to continue loading up until the mid $6 range, then I’ll let it ride through phase 3 trials . I’m not saying it will jump up in 1 day, but as the phase 3 trials starts, this will essentially be an incredibly safe bet.
I usually stay away from biotech stocks, but I’ve got a relative that works at IMRX , and I’ve been able to hit it perfectly the last 12-16 months . I have some big faith in this one over the next 4-8 months .
IMRX — no debt , insiders buys like crazy lately , already funded through 2029 so no dilution. Their phase 2 readout wasn’t even bad at all, and the market over reacted like crazy. Their overall survival rate was 64%, and the market was hoping for 75%. But the 64% is still nearly double the standard of care . Also the 64% was after 13 1/2 months, not 12 months . So it might have been a little higher . In my opinion, this is one of the best upside potentials on the market. I’ve been loading up since the low $4 range, and I’ll keep buying until $6.50, then letting it ride until halfway through phase 3 trials when I re evaluate. Phase 3 starts in June, and they have tumor shrinkage updates coming soon, along with a couple another potential catalysts. They have like $240m in cash. So it’s not a risk of any dilution. CEO said they are funded through 2029. The upside potential is huge on this one . They partnered with LLY and some other big names . I started buying at $1.50, and rode it up to like $9. Then bought again at $5.50 and rode it to $8. Now I’ve been loading again . I’ve got a relative that works there , so I know the potential is great for them.
IMRX - No debt, insider buys almost every day lately , massive over reaction from the market a few weeks ago, funded through 2029 so no dilution , phase 3 trials start in June . One of the best upside potential stocks I’ve found lately . Been buying like crazy the last 2 weeks, and planning to hold until the 2nd readout on phase 3 trials and see how it looks .
It actually ran up faster than I expected. I figured it would be between $3-$5 when the housing market got better . So it was a pleasant surprise that it’s already up this much. It will really depend on the next earnings call. I’ve been buying IMRX like crazy the past 2 weeks
I’ve been buying IMRX from the low $4 range. I’ve bought like a madman lately . (Not saying anyone else should buy it, just stating what I’ve been buying) there’s no telling if it goes up or down in the near term, but I’m very confident in it between now and mid - late summer time
Awesome ! Glad to hear it . I’ve been buying IMRX since it hit like $4.15. Insiders have been buying almost daily . Expecting to get around $$7-$9 by June when phase 3 starts . No debt, insider buying , great results on their med. Massive market over reaction a few weeks ago . The news wasn’t even bad in the slightest way.. I’m not saying to buy it or not. But I’ve been buying like crazy, and I’ll probably keep adding until $6-$7. No chance for dilution either . They are funded through 2029
Some of the ones I followed today IMRX up 10% GORO up 17% Rime up 33% Segg -10% Honestly, do yourself a favor and stay away from meme stocks like Segg (which is basically everyone hoping it will rocket short term gains and unsustainable) and IBRX (unless you bought low already). The Stock Market is pretty random with who it chooses to bless at our level, so don't use money you can't afford to lose and believe in the stockmarket
lol exactly! I’m not big in the bio tech stocks, but I have family that works at IMRX , so I got in around $1.50. I mentioned it before their LLY partnership on here when it was like $1.50. Unfortunately with the data that came out yesterday, only 3 people in the company can see the results , that way there’s no insider trading. So my relative wasn’t able to see the data ahead of time unfortunately. It will climb back up again. They have no debt and a fat pile of $240m cash
I sold the shares I bought the last couple weeks near market close . Made like 20% on my money. I hold shares at a cost of like $2.50 average also. Their readout data was really good , but it wasn’t as good as expected. But usually these stocks are good to buy a few weeks ahead of a catalyst, then cash out the day of the news . Although, IMRX actually has some serious potential long term. I hold a good chunk of shares still
Thanks ! IMRX is way up today. I’ve been telling people all week lol. Some of my picks take a few months or more to pop though .
I bought more LFMD today. My company hired ONDS so i learned about them because they used drones to inspect our equipment. I was interested in space stuff and I spend about 2 hours per day researching, so I found those. ASTS had their office next door to our business in west Texas , so I met a few of the technicians there, and they took me in a walkthrough when the stock price was like $3. I never expected it to run this high, but I bought a good chunk of shares the day they let me come walk in their shop. RKLB I bought because I thought it would be huge as the future went on. I didn’t expect it to grow this fast though. IMRX I have family that works there so I knew about the LLY partnership. I mentioned it on Reddit when it was $1.50. Then it ran to $9. I’ve been mentioning IMRX on Reddit the past week, and it’s up huge today for their OS readout . I like to get in and accumulate shares of good companies a few months before they take off. Sometimes it’s faster than I expected, and sometimes it’s slower . My real estate play (BLNE) might take a bit longer to take off, due to economic reasons. But I’m confident in it for later this summer
IMRX rising nicely into tonight's news
Opinions on IMRX, institutional ownership went up over 6x since a few months ago, trial data coming today?
IMRX has their 12 month OS readout after hours on Wednesday. The company has no debt. $230m in cash , so no dilution. Lots of insider buying . Volume has been increasing the last few trading days . Good luck !
Big update for DGXX https://www.accessnewswire.com/newsroom/en/blockchain-and-cryptocurrency/digi-power-x-announces-1-150-year-over-year-liquidity-growth-and-prov-1124350 IMRX has their 12 month OS readout tomorrow after hours .
IMRX has their 12 month OS readout tomorrow after hours . Their 9 month readout caused a short squeeze. They have no debt and a mountain of cash
IMRX has their 12 month OS readout on January 7. There’s some big potential there. LFMD for a good value , get it at the bottom before it runs again after they announced a partnership with NVO today . DGXX one of the best value bitcoin mining companies that turned HPC / data center . They are expecting an announcement for a contract any day now . BLNE to get In a real estate play before the market rotates into that sector . This will be an easy 2x + in the next few months
IMRX has 12 month OS readout on January 7 for pancreatic cancer treatment in phase 2 trials
ONDS , DGXX , LFMD , BLNE , (IMRX does their 12 month OS readout on the 7th this month, so there might be some good potential there too)
After doing a bit more research, my guess is they will release the phase 3 fda update , then (assuming it’s good) the stock price will run up a bit and they will do a share offering . That is the logical play. IMRX has 12 month OS readout on January 7 this week. On their 9 month update, the share price ran huge after hours , but they announced a share offering almost immediately. But now they have 3-4 years of cash.
IMRX has 12 month OS readout after hours on January 7 in case anyone wants to get in on the action
LFMD , DGXX , BLNE - these are a few more that haven’t popped yet. Lots of people post junk on Reddit. Looks like you got in early on some of the same stocks as I did . (ASTS , RKLB , ONDS , IMRX , HOOD) . It’s always good to see a few other people on here that don’t just post the same stuff that everyone else already posted, or some pump and dump company
IMRX and GANX have attractive entry points rn
SLS still is a gamble, there is a real case that current valuation is fair/high and people banking on something happening during JP Morgan event will probably be disappointed which could cause a (big) drop VKTX, IMRX and GANX have way more room for steep rises in the coming weeks imo
IMRX has 12 month OS data readout on January 7. Some huge potential possible !
I would live IMRX fails, and I gonna load on the dip :)
Have about 400 IMRX shares
BLNE for the housing market rebound DGXX for an undervalued bitcoin mining company that converted to data center stuff IMRX has 12 month readout coming January 7th
IMRX has their 12 month update coming January 7.
IMRX announcing news / updates / regulatory feedback on January 7. Volume has been increasing the last few days. This has some major potential. Last update in September caused a massive squeeze and the price ran to $17 after hours , before announcing a share offering . Now they have a mountain of cash and no debt . So this announcement could really move the price . Insiders have been buying the past few months also
If anyone wants to make some easy money… IMRX - big news coming https://www.investing.com/news/company-news/immuneering-to-provide-12month-survival-data-for-pancreatic-cancer-drug-93CH-4421095
IMRX - this will be huge https://www.investing.com/news/company-news/immuneering-to-provide-12month-survival-data-for-pancreatic-cancer-drug-93CH-4421095
Also check out IMRX - https://www.investing.com/news/company-news/immuneering-to-provide-12month-survival-data-for-pancreatic-cancer-drug-93CH-4421095
IMRX - better hurry https://www.investing.com/news/company-news/immuneering-to-provide-12month-survival-data-for-pancreatic-cancer-drug-93CH-4421095
Yes, IMRX is starting phase 3 trials in the coming months. Their pancreatic cancer treatment has been insanely good so far. They are expecting regulatory feedback in the next few weeks also
DGXX looking good for a possible continuation, are you expecting news on IMRX?
BLNE / DGXX / IMRX / maybe some BZFD
If you do enough research and find / hold good stocks , this isn’t true. I got ONDS at 70cents / got ASTS at $3.80 / RKLB at $4 / HIT at 80 cents before running to $3.50 / IMRX at $1.40 / BBAI at $2 . Along with some others I do hours of research each day. BLNE is my next pick to make a pile of money over the next few months
Please tell me about some penny stocks that have a guaranteed success rate and are a “sure bet” … The reason penny stocks are cheap is because you’re betting on a company that hasn’t fully proved itself yet. What are a few of your picks ? I got in ASTS and RKLB at $4. ONDS at 70cents , HIT at 60cents , IMRX at $1.10 , bought BYND at 62cents and sold at $4.5 , OUST at $7 , DPRO at $2.50 . I do hours of research every day to find small cap stocks . Every stock has risk . The goal is to find the ones with “less risk” , and follow them closely.
BLNE would be top pick . I keep adding shares multiple times per week. IMRX will be an easy 2x-3x over the next 6 months if their next trials go good . BLNE has lots of insider buying , ceo has $16m of his own cash in it , expecting profitability by q1 2026, already cash flow positive, no debt , record revenue, rate cuts coming , new blockchain home equity product is already completely booked out . Lots of great things coming from BLNE . Easy money from here! Plus they have enough cash and said there won’t be any more dilution
“Thank you. Among IMRX, RDZN, DGXX, and BLNE, which one would you consider your top pick?”
I usually just ease into them. I try to look for small cap companies that are nearing profitability, or cash flow positive. I like to see enough cash on hand where they won’t need to dilute much. Revenue needs to be growing faster than normal. They need to have an actual product that has been proven already and is getting sales . Partnerships with good businesses is a plus to me. The most important thing is management. Do they have their own money in it? Do they have proven experience? Can you believe what they say? I love companies that under promise and over deliver . I stay away from companies with management that hypes things up and then falls short. Those are the things I start with.. ONDS is my favorite. BLNE and RDZN are a few good longer holds . IMRX has some big potential. I also like potential turnaround companies like NFE because they can produce huge profits for shareholders that get in at the right time
IMRX lots insider buying. 20% Short interest positive trial results over 80% success in pancreatic cancer trial and cash runway till 2029. 🚀🚀🔥🔥
IMRX is a way way better cancer play
BLNE is crazy cheap right now, and earnings next week. Also DGXX , RDZN , IMRX
If you want a few other great small caps to research, IMRX , RDZN , DGXX are some others . BLNE and the 3 I just mentioned are my biggest conviction small cap plays for the next 6 months
Look at IMRX it has been quietly upticking the past few days
The same with IMRX, the problem is that I made the same mistake here with BYND and instead of doubling my portfolio I ended with -50% of it. When would I learn these lessons?
Yep, I learned the hard way on IMRX , so yesterday, when this stock got to 7 bucks, I got out
PCSA 10 k in at 0.278 Insiders bought and kept shares, clinical news coming, next IMRX
yeah i was watching an interview today about IMRX, QURE, and ABVX. All close to basically curing or changing the face of an illness or issue. QURE is for Huntington's Disease and ABVX is inflammatory disease.
Mostly 6+ month holds . IMRX will likely double by mid 2026 whenever they have the phase 3 trials going .
I’ve got a relative that works at IMRX . Back when it was under $2 I made a comment about the upcoming news , and it proceeded to run up to $9+ over a few months . The phase 2 results were great, and they did a share offering to have a nice cash runway . 4 insiders bought shares this last week, showing some major conviction. Once the price finds a bottom , it’s going to be a great stock to jump in and ride back up. Analysts price target is $8-$16+ , not that analysts mean anything. But , I’ve got a relative there, and they are pretty confident about that pancreatic cancer med . The only “iffy” part right now is some of the side effects it has caused . But the results so far have been amazing. IMRX is one of my plans for making some good money the next few months.
Agree on HIT. What do you like about IMRX? Are you in RZLV?
all biotech stocks are penny stocks at the start until a catalyst happens, look at IMRX
IMRX...Not a penny stock but dropped 22%. in the last week and just had really good news. See below. Stock is cheap and PT is 10.00 (currently 6.49) May be especially interesting for those that buy and hold for several days or longer. https://finance.yahoo.com/news/positive-trial-data-supports-43-154216933.html
Tomorrow discussion about some project / really succesful analyst rated it as a strong buy and price target 2$ (July)/ someone made a post, so yolo/ I just have a feeling about it, same as I had with CYCU, NVNI, IMRX, GPUS, BITF (biggest catalyst possible)
I don’t see any time on the chart where it got to 20cents ? It says 20cents at the 52 week low on Robinhood though. I look for medium to longer term holds . Businesses that are growing and have great leadership. I found ONDS at like 70cents, HIT at 80cents , IMRX at $2 , DPRO at $2 , and now I believe this one will be a great one to accumulate. BLNE has some potential also. I’m surprised more people don’t mention it
IMRX hit like a mack truck today
Amazing… I’m in heavy on IMRX. You?
IMRX went on a fat run. I just sold the rest of mine today .
Thank you for posting these every week, I did made some nice amount of profit on SCLX, AVBP and IMRX. Love you man! Keep doing what you are doing...
IMRX has been ripping the last 2 months
It’s been a strong couple weeks for IMRX !
IMRX - Incredible news from their last drug trial update. They said in the investor update that their drug was so effective at treating pancreatic cancer, that they were going to start testing it for treating multiple kinds of cancers.
I love IMRX, I've been holding an adding for a few weeks now. Their drug test results for their pancreatic cancer treatment was groundbreaking.
$IMRX $CNVS are all green and gaining
i made butt load of gains from IMRX, seems like you lost out on money lmao
IMRX - immuneering - lots of insider buying lately, really good news with phase 2 pancreatic cancer treatment results, phase 3 starting soon. I’m in it for 13,000 shares. One of my friends is a pharmaceutical rep for them, and he said most of the employees and their families have been buying stock the last few months. He said they know things about 2-3 weeks ahead of the general public. I’ll continue to update as new info comes out
I’m hood rich thanks to IMRX volatility over the past couple of weeks. One more dip and run and I’ll be swimming in hookers.
IMRX Not financial advice
News earlier on IMRX Not financial advice
IMRX not financial advice
IMRX Not financial advice
IMRX Not financial advice
IMRX Not financial advice
Certainly! Immuneering Corporation (IMRX) is currently trading at $2.04, showing a slight upward momentum with the 10-day SMA at $1.89 and the 30-day SMA at $2.01, indicating a potential bullish trend. The RSI values are moderate, suggesting neither overbought nor oversold conditions, while the MACD histogram is positive, supporting a short-term bullish outlook. Despite low trading volume today, the stock has shown resilience around the $2 mark, which could act as a psychological support level. Given the broader market’s cautious sentiment and mixed technical signals, IMRX might experience moderate volatility. For today’s session, consider a LONG position with an entry around $2.00, targeting $2.10 as the first price target and $2.20 as the second, with a stop loss at $1.90 to manage downside risk. Confidence in reaching the first target is moderate due to the current technical setup, while the second target carries lower confidence given external market pressures. Investors should remain vigilant of broader market movements and sector-specific news that could impact IMRX’s trajectory.